Literature DB >> 11051618

Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.

W Sougakoff1, V Jarlier.   

Abstract

The activity of mecillinam, a beta-lactam antibiotic with high affinity for gram-negative penicillin-binding protein 2 (PBP2), was assessed against ampicillin-resistant Escherichia coli strains producing beta-lactamases representing the three molecular classes, A (TEM-1 and -3, SHV-3 and IRT-5), C (AmpC) and D (OXA-3). The antimicrobial activity of mecillinam and other beta-lactam antibiotics was evaluated by determining their MICs on Mueller-Hinton agar. The time course of hydrolysis in crude extracts prepared from the various beta-lactamase-producing strains was also measured and was used to determine the relative rate of hydrolysis and the apparent affinity for ampicillin, cephalothin and mecillinam. When compared with the other beta-lactam antibiotics, mecillinam demonstrated significantly greater antibacterial potency and higher stability to beta-lactamase hydrolysis in TEM-, IRT- and AmpC-producing isolates. These findings confirm that the antimicrobial potency of mecillinam compares favourably with those of the other penicillins included in the present study, suggesting that mecillinam use in the treatment of infections caused by gram-negative bacteria should be re-evaluated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11051618

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents.

Authors:  T Mazzulli; M Skulnick; G Small; W Marshall; D J Hoban; G G Zhanel; S Finn; D E Low
Journal:  Can J Infect Dis       Date:  2001-09

2.  High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.

Authors:  Arne Søraas; Arnfinn Sundsfjord; Silje Bakken Jørgensen; Knut Liestøl; Pål A Jenum
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

3.  Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.

Authors:  Fardod O'Kelly; Siobhan Kavanagh; Rustom Manecksha; John Thornhill; Jérôme P Fennell
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

4.  Diverse Stress-Inducing Treatments cause Distinct Aberrant Body Morphologies in the Chlamydia-Related Bacterium, Waddlia chondrophila.

Authors:  Aurélie Scherler; Nicolas Jacquier; Carole Kebbi-Beghdadi; Gilbert Greub
Journal:  Microorganisms       Date:  2020-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.